- Home
- NTRP vs ONVO Comparison
NTRP vs ONVO Comparison
Compare NTRP & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- ONVO
- Stock Information
- Founded
- NTRP 1985
- ONVO 2007
- Country
- NTRP United States
- ONVO United States
- Employees
- NTRP N/A
- ONVO N/A
- Industry
- NTRP
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTRP
- ONVO Health Care
- Exchange
- NTRP NYSE
- ONVO Nasdaq
- Market Cap
- NTRP 5.9M
- ONVO 6.5M
- IPO Year
- NTRP N/A
- ONVO N/A
- Fundamental
- Price
- NTRP $7.26
- ONVO $0.39
- Analyst Decision
- NTRP
- ONVO
- Analyst Count
- NTRP 0
- ONVO 0
- Target Price
- NTRP N/A
- ONVO N/A
- AVG Volume (30 Days)
- NTRP 45.3K
- ONVO 243.5K
- Earning Date
- NTRP 01-14-2025
- ONVO 02-06-2025
- Dividend Yield
- NTRP N/A
- ONVO N/A
- EPS Growth
- NTRP N/A
- ONVO N/A
- EPS
- NTRP N/A
- ONVO N/A
- Revenue
- NTRP $623,664.00
- ONVO $103,000.00
- Revenue This Year
- NTRP $499.45
- ONVO $59.08
- Revenue Next Year
- NTRP $363.49
- ONVO $18.24
- P/E Ratio
- NTRP N/A
- ONVO N/A
- Revenue Growth
- NTRP 186.93
- ONVO N/A
- 52 Week Low
- NTRP $1.39
- ONVO $0.32
- 52 Week High
- NTRP $8.50
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- NTRP 64.99
- ONVO 47.81
- Support Level
- NTRP $6.25
- ONVO $0.34
- Resistance Level
- NTRP $8.25
- ONVO $0.51
- Average True Range (ATR)
- NTRP 0.95
- ONVO 0.06
- MACD
- NTRP -0.08
- ONVO -0.00
- Stochastic Oscillator
- NTRP 63.53
- ONVO 30.00
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.